Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?

J Endocrinol Invest. 1998 Oct;21(9):632-5. doi: 10.1007/BF03350790.
No abstract available

Publication types

  • Review

MeSH terms

  • Chromans / therapeutic use
  • Female
  • Humans
  • Hyperinsulinism / complications
  • Hyperinsulinism / drug therapy*
  • Hypoglycemic Agents
  • Metformin / therapeutic use
  • Polycystic Ovary Syndrome / etiology*
  • Polycystic Ovary Syndrome / therapy
  • Thiazoles / therapeutic use
  • Thiazolidinediones*
  • Troglitazone

Substances

  • Chromans
  • Hypoglycemic Agents
  • Thiazoles
  • Thiazolidinediones
  • Metformin
  • Troglitazone